危及生命的喘恶化病例成功用本拉利祖马布治疗
Suzuka Matsuoka1, Kenichiro Kudo1, Mayu Goda1
1Department of Respiratory Medicine, NHO Okayama Medical Center, Japan.
Internal medicine (Tokyo, Japan)
|January 15, 2025
概括
一种严重的喘恶化不响应标准治疗,通过单剂量本拉利祖马布迅速得到解决. 这种生物疗法为严重的耐火性支气管喘提供了一个有前途的选择.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘恶化可能导致呼吸衰竭,需要机械通风.
- 像支气管扩展剂和皮质类固醇等标准治疗有时对严重支气管来说是不够的.
- 生物药物代表了对严重,耐火性呼吸道疾病的新疗法.
研究的目的:
- 评估本拉利祖马布在患有严重,危及生命的喘恶化患者的疗效.
- 评估本拉利祖马布在耐火性支气管的情况下对呼吸系统参数的影响.
主要方法:
- 一名52岁的男性有喘病史,呈现出进展性呼吸不良和头过度.
- 尽管进行了强化标准的医学治疗,包括上腺素,沙尔布塔摩尔和甲基prednisolone,患者需要输管和机械通风.
- 一次剂量的生物药物本拉利祖马布被管理.
主要成果:
- 在服用本拉利祖马布后,观察到呼吸状况显著改善.
- 二氧化碳的部分压力 (pCO2),潮体积和气道阻力正常化.
- 患者在治疗后两天成功地被抽管.
结论:
- 本拉利祖马布证明了严重,耐火性支气管和呼吸衰竭的快速有效解决.
- 这一案例凸显了本拉利祖马布作为严重喘恶化不响应常规疗法的关键干预措施的潜力.
- 生物疗法为患有严重,危及生命的喘患者提供了有价值的治疗选择.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
231
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
231
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349


